Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Diabetic chronic HCV patients and their response to interferon therapy

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Impact of serum levels of AFP onresponse to treatment ingenotype 4 chronic HCV patients

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study

The relation between HCV viraemia and splenic volume in chronic HCV infected patients

Serum levels of AFP after interferon-based therapy with ribavirin for genotype 4 chronic HCV patients